3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
6
Carcinoid Tumor
5
Neoplasms
4
Carcinoma
3
Vipoma
2
Neoplasm Metastasis
2
Intestinal Obstruction
2
Carcinoma, Islet Cell
2
Somatostatinoma
1
Recurrence
1
Prostatic Neoplasms
1
Primary Inoperable Thymoma
1
Pleural Effusion
1
Peritoneal Neoplasms
1
Malignant Carcinoid Syndrome
1
Lymphangiomyoma
1
Lymphangioleiomyomatosis
1
Insulinoma
1
Glucagonoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Gastrinoma
1
Diarrhea
1
Chylous Ascites
1
Chylothorax
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Ascites
1
Adenoma, Islet Cell
1
Interventions
Erlotinib Hydrochloride
2
dehydroftorafur
1
X-Rays
1
Surgical Procedures, Operative
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Phantoms, Imaging
1
Magnetic Resonance Spectroscopy
1
Immunohistochemistry
1
Gemcitabine
1
Fluorouracil
1
Drug Therapy
1
Congresses as Topic
1
Capecitabine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pancreatic Intraductal Neoplasms
×
Octreotide
×
Clear all
No trials found.